AstraZeneca Plc
(NASDAQ) AZN
This security has been delisted. This page is retained for historical reference.
AZN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAZN Financials
Key Financial Metrics (TTM)
Gross Margin
79.71%
Operating Margin
23.53%
Net Income Margin
17.19%
Return on Equity
22.41%
Return on Capital
17.54%
Return on Assets
9.17%
Earnings Yield
N/A
Dividend Yield
1.84%
Payout Ratio
46.98%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$49.37B
Operating Income
$14.32B
EBITDA
$20.47B
Operating Cash Flow
$14.31B
Capital Expenditure
-$6.24B
Free Cash Flow
$8.07B
Cash & ST Invst.
$7.68B
Total Debt
$33.92B
AstraZeneca Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.29B
+12.5%
Gross Profit
$12.61B
+11.1%
Gross Margin
82.48%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
94,300
N/A
Net Income
$3.08B
+5.6%
EBITDA
$5.67B
+12.7%
Quarterly Fundamentals
Total Cash
$7.68B
+42.3%
Total Debt
$33.92B
+6.9%
Accounts Receivable
$14.11B
+6.5%
Inventory
$6.57B
+11.7%
Long Term Debt
$25.96B
-7.1%
Short Term Debt
$7.96B
+110.6%
Return on Assets
9.17%
N/A
Return on Invested Capital
17.57%
N/A
Free Cash Flow
$1.82B
-33.6%
Operating Cash Flow
$3.36B
-9.5%